Rennova Health, Inc. (RNVA)
OTCMKTS: RNVA · Delayed Price · USD
0.0001
+0.0001 (9,900.00%)
Apr 25, 2024, 3:07 PM EDT - Market closed

Rennova Health Statistics

Total Valuation

Rennova Health has a market cap or net worth of $4.31 million. The enterprise value is $16.42 million.

Market Cap 4.31M
Enterprise Value 16.42M

Important Dates

The last earnings date was Thursday, December 12, 2019, before market open.

Earnings Date Dec 12, 2019
Ex-Dividend Date n/a

Share Statistics

Rennova Health has 43.05 billion shares outstanding. The number of shares has increased by 197.09% in one year.

Shares Outstanding 43.05B
Shares Change (YoY) +197.09%
Shares Change (QoQ) -93.49%
Owned by Insiders (%) n/a
Owned by Institutions (%) 6.69%
Float n/a

Valuation Ratios

The trailing PE ratio is 0.00.

PE Ratio 0.00
Forward PE n/a
PS Ratio 0.21
Forward PS n/a
PB Ratio n/a
P/FCF Ratio 1.16
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.31, with an EV/FCF ratio of 4.41.

EV / Earnings 6.94
EV / Sales 0.81
EV / EBITDA 3.31
EV / EBIT 3.57
EV / FCF 4.41

Financial Position

Current Ratio n/a
Quick Ratio 0.11
Debt / Equity n/a
Debt / EBITDA 2.47
Debt / FCF 3.28
Interest Coverage 13.50

Financial Efficiency

Return on equity (ROE) is -8.59% and return on invested capital (ROIC) is -19.12%.

Return on Equity (ROE) -8.59%
Return on Assets (ROA) 11.92%
Return on Capital (ROIC) -19.12%
Revenue Per Employee $238,855
Profits Per Employee $27,840
Employee Count 85
Asset Turnover n/a
Inventory Turnover 27.77

Taxes

In the past 12 months, Rennova Health has paid $591,810 in taxes.

Income Tax 591,810
Effective Tax Rate 20.01%

Stock Price Statistics

Beta (1Y) 53.11
52-Week Price Change n/a
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 53.71
Average Volume (30 Days) 38,485,226

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.84

Income Statement

In the last 12 months, Rennova Health had revenue of $20.30 million and earned $2.37 million in profits. Earnings per share was $0.05.

Revenue 20.30M
Gross Profit 12.81M
Operating Income 3.65M
Pretax Income 3.01M
Net Income 2.37M
EBITDA 4.96M
EBIT 4.60M
Earnings Per Share (EPS) $0.05
Full Income Statement

Balance Sheet

The company has $123,898 in cash and $12.24 million in debt, giving a net cash position of -$12.11 million or -$0.00 per share.

Cash & Cash Equivalents 123,898
Total Debt 12.24M
Net Cash -12.11M
Net Cash Per Share -$0.00
Equity / Book Value -27.56M
Book Value Per Share -0.00
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $4.05 million and capital expenditures -$323,963, giving a free cash flow of $3.73 million.

Operating Cash Flow 4.05M
Capital Expenditures -323,963
Free Cash Flow 3.73M
FCF Per Share $0.00
Full Cash Flow Statement

Margins

Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.

Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%

Dividends & Yields

Rennova Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -197.09%
Shareholder Yield -197.09%
Earnings Yield 54.97%
FCF Yield 86.56%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on March 16, 2022. It was a reverse split with a ratio of 1:10000.

Last Split Date Mar 16, 2022
Split Type Reverse
Split Ratio 1:10000

Scores

Altman Z-Score n/a
Piotroski F-Score 6